Abstract
Objectives. To review the role of Wnt pathways in the neurodevelopment of schizophrenia.
Methods: Systematic PubMed search, using as keywords all the terms related to the Wnt pathways and crossing them with each of the following areas: normal neurodevelopment and physiology, neurodevelopmental theory of schizophrenia, schizophrenia, and antipsychotic drug action.
Results: Neurodevelopmental, behavioural, genetic, and psychopharmacological data point to the possible involvement of Wnt systems, especially the canonical pathway, in the pathophysiology of schizophrenia and in the mechanism of antipsychotic drug action. The molecules most consistently found to be associated with abnormalities or in antipsychotic drug action are Akt1, glycogen synthase kinase3beta, and beta-catenin. However, the extent to which they contribute to the pathophysiology of schizophrenia or to antipsychotic action remains to be established.
Conclusions: The study of the involvement of Wnt pathway abnormalities in schizophrenia may help in understanding this multifaceted clinical entity; the development of Wnt-related pharmacological targets must await the collection of more data.
Keywords: Antipsychotic Drugs; Neurodevelopment; Schizophrenia; Wingless (Wnt) signalling.
Current Neuropharmacology
Title:Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways
Volume: 11 Issue: 5
Author(s): Elisa Ambrosi, Gabriele Sani, Paolo Girardi, Ferdinando Nicoletti, Marta Motolese, Delfina Janiri, Giovanni Manfredi, Emanuela Danese, Lavinia De Chiara, Valeria Savoja, Alessio Simonetti, Isabella Panaccione, Ilaria Cuomo, Federica Caccia, Daniele Serata, Chiara Brugnoli, Chiara Rapinesi, Antonio Del Casale, Giorgio D. Kotzalidis, Alberto Maria Forte and Flavia Napoletano
Affiliation:
Keywords: Antipsychotic Drugs; Neurodevelopment; Schizophrenia; Wingless (Wnt) signalling.
Abstract: Objectives. To review the role of Wnt pathways in the neurodevelopment of schizophrenia.
Methods: Systematic PubMed search, using as keywords all the terms related to the Wnt pathways and crossing them with each of the following areas: normal neurodevelopment and physiology, neurodevelopmental theory of schizophrenia, schizophrenia, and antipsychotic drug action.
Results: Neurodevelopmental, behavioural, genetic, and psychopharmacological data point to the possible involvement of Wnt systems, especially the canonical pathway, in the pathophysiology of schizophrenia and in the mechanism of antipsychotic drug action. The molecules most consistently found to be associated with abnormalities or in antipsychotic drug action are Akt1, glycogen synthase kinase3beta, and beta-catenin. However, the extent to which they contribute to the pathophysiology of schizophrenia or to antipsychotic action remains to be established.
Conclusions: The study of the involvement of Wnt pathway abnormalities in schizophrenia may help in understanding this multifaceted clinical entity; the development of Wnt-related pharmacological targets must await the collection of more data.
Export Options
About this article
Cite this article as:
Ambrosi Elisa, Sani Gabriele, Girardi Paolo, Nicoletti Ferdinando, Motolese Marta, Janiri Delfina, Manfredi Giovanni, Danese Emanuela, Chiara De Lavinia, Savoja Valeria, Simonetti Alessio, Panaccione Isabella, Cuomo Ilaria, Caccia Federica, Serata Daniele, Brugnoli Chiara, Rapinesi Chiara, Casale Del Antonio, Kotzalidis D. Giorgio, Forte Maria Alberto and Napoletano Flavia, Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways, Current Neuropharmacology 2013; 11 (5) . https://dx.doi.org/10.2174/1570159X113119990037
DOI https://dx.doi.org/10.2174/1570159X113119990037 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets Experimental Brain Ischemic Preconditioning: A Concept to Putative Targets
CNS & Neurological Disorders - Drug Targets Recent Advances in Liver X Receptor Biology and Chemistry
Current Topics in Medicinal Chemistry BACE Inhibitors as Potential Drugs for the Treatment of Alzheimers Disease: Focus on Bioactivity
Recent Patents on CNS Drug Discovery (Discontinued) Epigenetic Drugs for Multiple Sclerosis
Current Neuropharmacology Withaferin A Regulates LRRK2 Levels by Interfering with the Hsp90- Cdc37 Chaperone Complex
Current Aging Science Presynaptic Cell Dependent Modulation of Inhibition in Cortical Regions
Current Neuropharmacology Upregulation of Focal Adhesion Kinase by 14-3-3ε via NFκB Activation in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Current Drug Metabolism MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
Current Drug Targets Synthetic Lethality to Overcome Cancer Drug Resistance
Current Medicinal Chemistry Bergamot Juice Extract Inhibits Proliferation by Inducing Apoptosis in Human Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Natural Products Containing Olefinic Bond: Important Substrates for Semi-synthetic Modification Towards Value Addition
Current Organic Chemistry Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis
Current Drug Targets Small-molecule Modulation of HDAC6 Activity: The Propitious Therapeutic Strategy to Vanquish Neurodegenerative Disorders
Current Medicinal Chemistry Mechanism of Action of Limonene in Tumor Cells: A Systematic Review and Meta-Analysis
Current Pharmaceutical Design Radionuclides Used in Nuclear Medicine Therapy – From Production to Dosimetry
Current Medical Imaging Scientific Basis for the Use of Indian Ayurvedic Medicinal Plants in the Treatment of Neurodegenerative Disorders: 1. Ashwagandha
Central Nervous System Agents in Medicinal Chemistry Molecular and Biological Heterogeneity in Neuroblastoma
Current Genomics Recent Advances in Improving Sub-Unit Vaccine Efficacy Using Cytokines as more Specific Immune Inducing Adjuvants
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry